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Summary
The longevity-assurance activity of the tumor suppres-
sor p53 depends on the levels of D40p53 (p44), a short
and naturally occurring isoform of the p53 gene. As
such, increased dosage of p44 in the mouse leads to
accelerated aging and short lifespan. Here we show
that mice homozygous for a transgene encoding p44
(p44
+ ⁄ +) display cognitive decline and synaptic impair-
ment early in life. The synaptic deﬁcits are attributed
to hyperactivation of insulin-like growth factor 1 recep-
tor (IGF-1R) signaling and altered metabolism of the
microtubule-binding protein tau. In fact, they were res-
cued by either Igf1r or Mapt haploinsufﬁciency. When
expressing a human or a ‘humanized’ form of the amy-
loid precursor protein (APP), p44
+ ⁄ + animals developed
a selective degeneration of memory-forming and
-retrieving areas of the brain, and died prematurely.
Mechanistically, the neurodegeneration was caused by
both paraptosis- and autophagy-like cell deaths. These
results indicate that altered longevity-assurance activity
of p53:p44 causes memory loss and neurodegeneration
by affecting IGF-1R signaling. Importantly, Igf1r hap-
loinsufﬁciency was also able to correct the synaptic
deﬁcits of APP695 ⁄ swe mice, a model of Alzheimer’s
disease.
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Introduction
Studies from model organisms have shown that an aging pro-
gram mediated by the insulin-like growth factor 1 receptor (IGF-
1R) regulates lifespan. In fact, hyperactivation of IGF-1R signal-
ing leads to accelerated aging and short lifespan, whereas par-
tial inhibition of IGF-1R delays aging and extends lifespan
(Tissenbaum & Guarente, 2002; Kenyon, 2005; Puglielli, 2008;
Ungewitter & Scrable, 2008). Additionally, genetic variations
that cause reduced IGF-1R signaling appear to be beneﬁcial for
old age survival in humans (van Heemst et al., 2005; Suh et al.,
2008), suggesting that the mechanisms regulating lifespan and
aging via this pathway are highly conserved.
In mammals, IGF-1R signaling is tightly controlled by the lon-
gevity-assurance activity of the tumor suppressor p53, speciﬁ-
cally D40p53 (Ungewitter & Scrable, 2008). D40p53 (also
referred to as DNp53 or p44) is one of several N-truncated iso-
forms encoded by the p53 gene, which lack the ﬁrst transactiva-
tion domain (Courtois et al., 2002; Yin et al., 2002; Ghosh
et al., 2004; Bourdon et al., 2005). It has become evident that
the biological functions of wild-type p53 do not simply depend
on the expression levels of the full-length protein but also on the
interplay between the different isoforms (Courtois et al., 2002;
Yin et al., 2002; Ghosh et al., 2004; Bourdon et al., 2005).
In genetically altered mice, truncation of the N-terminus of
full-length p53 (p53
+ ⁄ m mice) (Tyner et al., 2002) or increased
dosage of D40p53 (p44
+ ⁄ + mice) (Maier et al., 2004) results in
premature and accelerated aging and in reduced longevity. In
p44
+ ⁄ + mice, this has been linked to altered function of full-
length p53 and to the consequent hyperactivation of IGF-1R
signaling. In fact, a delicate balance between p53 and D40p53
(p44) is thought to control both expression levels and signaling
activity of IGF-1R (Bauer & Helfand, 2006; Rodier et al., 2007;
Ungewitter & Scrable, 2008). Increased activity of D40p53
(p44) in the mouse tilts the balance toward hyperactivation of
IGF-1R signaling and leads to accelerated aging (Maier et al.,
2004). Importantly, the deletion of p53 in p44
+ ⁄ + mice abol-
ishes the progeroid phenotype of the animals (Maier et al.,
2004), indicating that it is the p53:p44 system and not
D40p53 (p44) alone that regulates the aging program. To
date, a total of six mouse models with altered p53 activity have
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lbeen generated, and in all of them age-associated events and
lifespan are altered. Collectively, they leave little doubt that
the p53:p44 system has longevity-assurance activity (Bauer &
Helfand, 2006; Rodier et al., 2007; Ungewitter & Scrable,
2008).
Here, we report that altered longevity-assurance activity of
the p53:p44 system in p44
+ ⁄ + transgenic mice leads to cognitive
decline and synaptic impairment. The synaptic deﬁcits are attrib-
uted to hyperactivation of IGF-1R signaling and altered metabo-
lism of the microtubule-binding protein tau, and can be rescued
by Igf1r or Mapt haploinsufﬁciency. Additionally, when crossed
with mice expressing a ‘humanized’ form of mouse amyloid pre-
cursor protein (APP), p44
+ ⁄ + animals develop a selective degen-
eration of memory-forming and -retrieving areas of the brain
and die prematurely. The neuronal degeneration is caspase- and
apoptosis-independent and involves co-activation of paraptosis-
and autophagy-like cell death. Finally, we show that haploinsuf-
ﬁciency of Igf1r is also able to correct the synaptic deﬁcits of
APP695 ⁄ swe mice, a commonly used model of Alzheimer’s dis-
ease (AD).
Results
p44
+ ⁄ + mice show memory impairment and synaptic
defects as a result of IGF-1R hyperactivation and
abnormal tau metabolism
To assess whether overexpression of p44 in the mouse causes
cognitive decline, we performed a systematic evaluation of
p44
+ ⁄ + transgenic mice by using a combination of cognitive,
electrophysiological, and histological approaches. As shown in
Fig. 1A, p44
+ ⁄ + mice displayed a marked defect in associative
memory retrieval, as assessed by contextual- and cued-fear con-
ditioning tests, which explore amygdala and hippocampal func-
tions. The memory impairment occurred very early in life
(already evident at the age of 2.5 months) and in the absence of
general locomotor or behavioral abnormalities, as assessed with
the open-ﬁeld test (Fig. S1). Similar deﬁcits were observed in
older mice with the Barnes maze test. The Barnes maze is more
speciﬁc for spatial navigational memory, which is a hippocam-
pal-dependent activity. p44
+ ⁄ + transgenic animals displayed
Fig. 1 p44
+ ⁄ + single-transgenics display memory
and synaptic defects. (A) Fear conditioning
assessment of 2.5-month-old male p44
+ ⁄ + (n =9 )
and nontransgenic (non-Tg; n = 14) littermates.
Results show percentage of freezing. (B–D) Barnes
maze assessment of 10-month-old male p44
+ ⁄ +
and non-Tg littermates showing latency to enter in
the goal box (B, n = 12, both groups), distance
traveled (C, n = 6, both groups) and number of
errors (D, n = 12, both groups). (E) Long-term
potentiation (LTP) induction in hippocampal slices
of 2.5-month-old male p44
+ ⁄ + and non-Tg
littermates. p44
+ ⁄ + [n = 37(12)] lack the late
component of LTP seen in non-Tg mice [n = 11(5)].
Inset: typical recordings at the beginning (prior to
stimulation) and end of the experiments.
Calibration: 1 mV, 1 ms. The basal synaptic
excitatory transmission, as assessed by paired-pulse
facilitation (PPF) and i ⁄o curves, is shown in Fig. S2.
All values are mean ± SEM. *P < 0.05,
**P < 0.005, #P < 0.0005.
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175increased latency in entering the goal box (Fig. 1B), increased
distance traveled (Fig. 1C), and increased number of errors
(Fig. 1D). Importantly, p44
+ ⁄ + mice did not show any signiﬁcant
improvement on the spatial navigational task with training
(Fig. 1B–D). In conclusion, the cognitive defects of p44
+ ⁄ + mice
were observed on different experimental paradigms and were
evident throughout their entire lives.
It has been suggested that negative changes in the postsynap-
tic component of the long-term potentiation (LTP), as assessed
in hippocampal brain slices, represent the electrophysiological
correlate of the learning decline that characterizes aging in ani-
mals (Hedden & Gabrieli, 2005; Yankner et al., 2008). There-
fore, we measured CA3-CA1 LTP, as induced by theta burst
stimulation (TBS) to the Schaffer collaterals, in hippocampal
slices from 2.5-month-old p44
+ ⁄ + and nontransgenic (non-Tg)
littermates. p44
+ ⁄ + transgenics exhibited normal induction of
the ﬁeld excitatory postsynaptic potential (fEPSP) slope (Fig. 1E).
However, after the initial 30 min, this transient potentiation
decayed drastically (relative to non-Tg littermates), indicating
that p44
+ ⁄ + mice lack the late component of LTP. The paired-
pulse facilitation (PPF), a measure of presynaptic contribution to
synaptic transmission and a known form of short-term synaptic
plasticity, did not differ from non-Tg littermates (Fig. S2), indi-
cating that p44
+ ⁄ + mice only lack the postsynaptic component
of LTP. The electrophysiological deﬁcits of the hippocampal
brain slices (Fig. 1E) reﬂect very well the cognitive defects of the
living animals (Fig. 1A-D).
Dysregulation of the longevity-assurance activity of the
p53:p44 system, as caused by the overexpression of D40p53
(p44), leads to hyperactivation of IGF-1R signaling (Maier et al.,
2004), which in turn is thought to cause the progeroid pheno-
type of p44
+ ⁄ + animals (Bauer & Helfand, 2006; Rodier et al.,
2007; Ungewitter & Scrable, 2008). Consistently, p44
+ ⁄ + trans-
genic mice displayed increased levels of both IGF-1R and phos-
pho-IGF-1R, the activated form of the receptor, in the
hippocampal formation (Fig. 2A). To assess whether the synap-
tic deﬁcits displayed by p44
+ ⁄ + animals were directly related to
the ability of D40p53 (p44) to activate IGF-1R signaling, we
crossed p44
+ ⁄ + single-transgenics with mice lacking one copy of
Igf1r (Igf1r
+ ⁄ )) and generated p44
+ ⁄ +;Igf1r
+ ⁄ ) double-transgen-
ics. Disruption of both copies of Igf1r (Igf1r
) ⁄ )) is embryonically
lethal whereas disruption of only one copy (Igf1r
+ ⁄ )) extends
lifespan in the absence of obvious pathological manifestations
(Holzenberger et al., 2003). Assessment of the synaptic trans-
mission and plasticity properties of p44
+ ⁄ +;Igf1r
+ ⁄ ) double-
transgenics revealed a signiﬁcant increase in both induction and
maintenance of the LTP of the ﬁeld excitatory postsynaptic
potential slope when compared to p44
+ ⁄ + single-transgenics,
thus indicating that the deﬁcits observed in p44
+ ⁄ + animals were
caused by hyperactivation of IGF-1R signaling (Fig. 2B; also dis-
cussed later).
Histological assessment of different regions of the central
nervous system of p44
+ ⁄ + transgenic animals revealed no abnor-
malities (see later), with the exception of the hyperphosphoryla-
tion of the microtubule-binding protein tau (Fig. 3A; see also
Fig. S7B). The anti-phospho-tau immunolabeling was performed
with different antibodies recognizing different ‘phospho-epi-
topes’ (p-Ser202, p-Thr205 and p-Ser356; see Figs 3A and S7B).
Importantly, phospho-tau immunoreactivity exhibited a somato-
dendritic distribution, thus resembling the typical ‘pretangle’
lesion observed in the brain of nondemented old individuals and
of patients affected by late-onset AD (Bancher et al., 1989). It is
worth noting that mouse tau differs from human both in the
primary sequence and in the alternative splicing of the different
A
B
Fig. 2 IGF-1R is responsible for the synaptic
deﬁcits of p44
+ ⁄ + animals. (A) Expression levels of
IGF-1R and phospho-IGF-1R (p-IGF-1R) in the
hippocampal formation of 2.5-month-old male
non-Tg, p44
+ ⁄ +, p44
+ ⁄ +;Igf1r
+ ⁄ ), and Igf1r
+ ⁄ )
animals. A representative Western blot of three
different animals is shown in the left panel,
whereas the percentage of change is shown in the
right panel (n = 4). (B) Enhanced hippocampal CA1
long-term potentiation (LTP) in 2.5-month-old
male p44
+ ⁄ +;Igf1r
+ ⁄ ) transgenic animals. Theta
burst stimulation (TBS)-induced LTP was enhanced
in p44
+ ⁄ +;Igf1r
+ ⁄ ) mice [n = 10(3)] when
compared to p44
+ ⁄ + single-transgenics
[n = 37(12)]. Insets: example traces before and
after LTP for each group. Calibration 1 mV, 1 ms.
No difference was observed in paired-pulse
facilitation (PPF) or i ⁄ o curves (data not shown). All
values are mean ± SEM. *P < 0.05; **P < 0.005,
#P < 0.0005.
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176isoforms. As a consequence, mouse tau does not generate the
classical paired helical ﬁlaments or neuroﬁbrillary tangles
that are observed in the brain of nondemented old individuals
and of patients affected by late-onset AD (Duyckaerts et al.,
2008).
Both AD and non-AD mouse models indicate that the abnor-
mal metabolism of tau can cause memory deﬁcits [reviewed in
(Lee et al., 2001)]. Additionally, mutations in the gene encoding
tau (Mapt) have been associated with frontotemporal forms of
dementia [reviewed in (Lee et al., 2001)]. Therefore, we ana-
lyzed whether tau was responsible for the synaptic deﬁcits
observed in p44
+ ⁄ + single-transgenics by studying the synaptic
transmission and plasticity properties of p44
+ ⁄ +;tau
+ ⁄ ) animals.
As expected, p44
+ ⁄ +;tau
+ ⁄ ) double-transgenic mice displayed
a 50% decrease in tau protein levels (Fig. 3B). LTP assessment
revealed that haploinsufﬁciency of the Mapt gene in
p44
+ ⁄ +;tau
+ ⁄ ) double-transgenics was able to correct the
deﬁciency in the late component of LTP observed in p44
+ ⁄ +
single-transgenics (Fig. 3C). It should be noted that Mapt hap-
loinsufﬁciency only improved the late component of LTP
whereas Igf1r hypoinsufﬁciency enhanced both the induction
phase and the late component of LTP (compare Figs 3C and 2B).
The early and late components of LTP are thought to differ in
the fact that the former is protein and RNA synthesis-indepen-
dent whereas the latter is protein and RNA synthesis-dependent.
Therefore, it is likely that IGF-1R signaling affects multiple
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Fig. 3 The abnormal metabolism of tau is
responsible for the synaptic deﬁcits of p44
+ ⁄ +
animals. (A) Immunostaining with AT8 antibody
shows abnormal tau phosphorylation (Ser202 and
Thr205) in the indicated subﬁelds of the
hippocampus and dentate gyrus of p44
+ ⁄ + mice
(v-xii). No staining is observed in non-Tg mice (i-iv).
(ix-xii) show higher magniﬁcation of the indicated
areas in (v-viii). AT8 immunoreactivity was mainly
localized in neuronal cell bodies. Nuclei were
counterstained with 4¢,6-diamidino-2-phenylindole
(DAPI) (blue). Scale bars: 40 lm( i-viii); 20 lm
(ix-xii). Animals were 2.5-month old when
analyzed. Immunostaining with a different anti-
phospho-tau antibody is shown in Fig. S7. (B)
Expression levels of tau in the hippocampal
formation of 2.5-month-old male p44
+ ⁄ + and
p44
+ ⁄ +;tau
+ ⁄ ) animals. A representative Western
blot of three different animals is shown in the left
panel, whereas the percentage of change is shown
in the right panel (n = 4). Tau
) ⁄ ) mice are included
as control for antibody speciﬁcity. ND: not
detected. (C) Enhanced hippocampal CA1 long-
term potentiation (LTP) in 2.5-month-old male
p44
+ ⁄ +;tau
+ ⁄ ) transgenic animals. Theta burst
stimulation (TBS)-induced LTP was enhanced in
p44
+ ⁄ +;tau
+ ⁄ ) mice [n = 7(4)] when compared to
p44
+ ⁄ + single-transgenics [n = 37(12)]. Insets:
example traces before and after LTP for each
transgenic group. Calibration 1 mV, 1 ms. No
difference was observed in paired-pulse facilitation
(PPF) or i ⁄o curves (data not shown). All values are
mean ± SEM. #P < 0.0005.
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177aspects of synaptic transmission, some of which are tau-inde-
pendent. It is also possible that compensatory mechanisms are
responsible for the apparent increase in the induction phase in
p44
+ ⁄ +;Igf1r
+ ⁄ ) double-transgenics (see also later).
Expression of a humanized form of mouse APP in
p44
+ ⁄ + mice causes reduced lifespan and massive
degeneration of memory-forming and -retrieving
areas of the brain
To investigate whether IGF-1R hyperactivation, as caused by
altered longevity-assurance activity of p53:p44, could cause AD-
like neurodegeneration in vivo, we bred homozygous p44-trans-
genic mice (p44
+ ⁄ +) with heterozygous APP695 ⁄ swe mice, which
express a modiﬁed mouse APP cDNA encoding the 695-amino
acid isoform with a ‘humanized’ amyloid b-peptide (Ab) domain
that includes the familial AD-associated Swedish double muta-
tion (K595N⁄M596L). APP695 ⁄ swe mice develop amyloid plaques
in advanced age but lack signiﬁcant memory loss or neurode-
generation (Borchelt et al., 1996; Savonenko et al., 2003). The
resulting p44
+ ⁄ +;APP695 ⁄ swe double-transgenic animals were
born with mendelian frequency and without visible defects.
Remarkably, they displayed a very short lifespan, with a median
survival of 2.3 months (Fig. 4A). At the moment of death, the
peripheral organs appeared normal with no obvious signs of
pathology⁄degeneration (Fig. S3). The only abnormalities that
we could identify were limited to the brain (see later).
The external layers of the neocortex in p44
+ ⁄ +;APP695 ⁄ swe
mice showed sparse eosinophilic neurons with dense cytoplasm
(Fig. S4A) and surrounded by few reactive astrocytes (Fig. S4B).
The cerebellum and the spinal cord appeared completely normal
and similar to non-Tg animals (Fig. S4A). The analysis of the hip-
pocampus and dentate gyrus (fascia dentata) revealed normal
cyto-architecture (see low-magniﬁcation images in the left panel
of Fig. 4B) excluding possible defects in migration and⁄or differ-
entiation of the neurons during development. This is consistent
with the fact that the double-transgenic animals did not display
signs of neurodegeneration at birth (data not shown). However,
the entire hippocampal formation of p44
+ ⁄ +;APP695 ⁄ swe mice
suffered from massive and widespread degeneration. In fact,
dense, shrunken, and highly eosinophilic (darkly stained) neu-
rons were extremely abundant and well evident throughout the
entire hippocampus and dentate gyrus (Fig. 4B,C; for p44
+ ⁄ +
and APP695 ⁄ swe single-transgenics see Fig. S5). They co-existed
with large vacuoles, thus resembling a ‘vacuolar-like’ form of
neurodegeneration (see also later in Fig. 9). Importantly, the
above phenotype was only evident in the double-transgenics as
the other littermates, including p44
+ ⁄ + and APP695 ⁄ swe single-
transgenics appeared normal and similar to non-Tg mice
(Fig. S5). The immunoreactivity to the astrocytic marker GFAP
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Fig. 4 Decreased lifespan and widespread
degeneration of the hippocampal formation in
double-transgenic p44
+ ⁄ +;APP695 ⁄ swe mice. (A)
Kaplan–Meier survival analysis for p44
+ ⁄ +
(squares), APP695 ⁄ swe (circles) and double-
transgenic p44
+ ⁄ +;APP695 ⁄ swe (triangles) mice. The
median survival time for p44
+ ⁄ +;APP695 ⁄ swe mice
was 69.5 days. In the double-transgenic group
(n = 19) no animal survived longer than 5 months.
At this time, the survival in the APP695 ⁄ swe (n = 16)
and p44
+ ⁄ + (n = 26) groups was 76.5% and
96.1%, respectively. The survival curves were
signiﬁcantly different (P < 0.0005). (B)
Hematoxylin and eosin stained brain sections of
2.5-month-old male non-Tg and
p44
+ ⁄ +;APP695 ⁄ swe double-transgenic mice. Bar in
left panel (2.5·): 400 lm; bar in right panel (10·):
100 lm. (C) Higher-magniﬁcation images of (B).
Bar: 50 lm. APP695 ⁄ swe and p44
+ ⁄ + animals are
shown in Fig. S5. DG: Dentate Gyrus; DGpo:
polymorph layer of the dentate gyrus; CA4(CA3)
indicates the part of CA3 that inserts into the
dentate gyrus.
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178revealed widespread astrogliosis (Fig. 5A), which appeared
much more severe in the areas that correspond to the synaptic
ﬁelds of the lateral perforant pathway and the commissural and
ipsilateral association systems (see also later in Figs 6 and S8).
This ﬁnding is consistent with the widespread degeneration
shown in Fig. 4 and was absent in age-matched non-Tg, p44
+ ⁄ +,
and APP695 ⁄ swe littermates (Fig. S6). Finally, the hippocampus
and dentate gyrus of p44
+ ⁄ +;APP695 ⁄ swe mice also displayed
abnormal phosphorylation of the microtubule-associated pro-
tein tau (Figs 5B andS7). Interestingly, the distribution pattern of
tau hyperphosphorylation in p44
+ ⁄ +;APP695 ⁄ swe double-trans-
genics was similar to that observed in p44
+ ⁄ + single-transgenics
(Fig. S7).
To analyze early changes in the synaptic organization of the
hippocampus and dentate gyrus, we performed Timm’s sulﬁde
silver staining, which allows the identiﬁcation of the abundant
zinc-containing synaptic terminals. Non-Tg, APP695 ⁄ swe and
p44
+ ⁄ + single-transgenic animals displayed the characteristic
laminar Timm’s staining (Figs 6A and S8), which directly corre-
lates with the synaptic ﬁelds of the different afferent systems
(for a detailed description see Fig. S8). In contrast,
p44
+ ⁄ +;APP695 ⁄ swe mice showed a severe loss of staining in the
areas corresponding to the commissural⁄ipsilateral association
systems and to the perforant pathway, which conduct informa-
tion from the entorhinal cortex to the dentate gyrus and CA3
areas of the hippocampus (Fig. 6A; for p44
+ ⁄ + and APP695 ⁄ swe
single-transgenics see Fig. S8). Only the mossy ﬁbers, which pro-
ject from the granule cells of the dentate gyrus to CA3 via the
polymorphic layer (hilus), could be visualized in the double-
transgenic animals, although less intensely than in non-Tg litter-
mates (Fig. 6A). Neither p44
+ ⁄ + nor APP695 ⁄ swe mice displayed
any alteration in the intensity or pattern of staining (Fig. S8). The
loss of Timm’s staining was already evident at 1.5 months of
age and represented the earliest alteration that we could detect,
before widespread degeneration of the hippocampus and den-
tate gyrus. These results suggest a functional disconnection of
the different subregions of the hippocampal formation, which
has also been described as a typical neuropathological feature
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Fig. 5 Widespread astrogliosis and tau hyperphosphorylation in the hippocampus and dentate gyrus of p44
+ ⁄ +;APP695 ⁄ swe double-transgenic mice. (A) Brain
sections of 2.5-month-old non-Tg and p44
+ ⁄ +;APP695 ⁄ swe double-transgenic mice were immunostained for GFAP (astrocytic marker; green) and NeuN (neuronal
marker; red). Nuclei were counterstained with 4¢,6-diamidino-2-phenylindole (DAPI) (blue). (i and ii) Low-magniﬁcation microphotographs showing GFAP
immunoreactivity in the hippocampus and dentate gyrus of non-Tg and double-transgenic animals. (iii-viii) Higher magniﬁcation of CA1, CA4 and dentate gyrus
(DG) of non-Tg (iii-v) and double-transgenic (vi-viii) mice. Arrowheads indicate the characteristic morphology of reactive astrocytes with hypertrophic soma and
thick processes surrounding degenerating neurons. (ix-xi) Higher magniﬁcation of reactive astrocytes indicated in (vi-viii). Scale bars: 400 lm( i and ii); 50 lm( iii-
viii) and 20 lm( ix-xi). APP695 ⁄ swe and p44
+ ⁄ + animals are shown in Fig. S6. (B) Immunostaining with AT8 antibody showing abnormal tau phosphorylation
(Ser202 and Thr205) in the indicated subﬁelds of the hippocampus and dentate gyrus from double-transgenic mice (v-viii). (ix-xii) Higher magniﬁcation of the
indicated areas in (v-viii). AT8 immunoreactivity was mainly localized in neuronal cell bodies. Nuclei were counterstained with DAPI (blue). Images (i-iv) are also
shown in Fig. 3A. Scale bars: 40 lm( i-viii); 20 lm( ix-xii). APP695 ⁄ swe and p44
+ ⁄ + animals, as well as immunostaining with a different anti-phospho-tau antibody,
are shown in Fig. S7. Animals were 2.5-month old when analyzed.
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179and a possible cause of the early memory loss in patients with
AD (Hyman et al., 1984).
The loss of Timm’s staining can indicate either functional alter-
ations or nonreversible degeneration of the synaptic terminals.
To distinguish between these possibilities, we immunolabeled
the same hippocampal areas with an antibody against the inte-
gral synaptic vesicle protein, synaptophysin. Figure 6(B) shows
an abundant and healthy synaptic network in non-Tg animals,
which was signiﬁcantly reduced in p44
+ ⁄ +;APP695 ⁄ swe mice.
These alterations are consistent with the phenotype described
earlier and support the conclusion that the loss of Timm’s stain-
ing is because of the degeneration of the synaptic terminals.
The studies described earlier indicate that the altered longev-
ity-assurance activity of p53:p44 in p44
+ ⁄ +;APP695 ⁄ swe mice
preferentially affects memory-forming areas of the brain. There-
fore, we analyzed the association ﬁbers of the corpus callosum,
which are involved in memory retrieval and high-order activities
requiring information transfer between the two hemispheres.
Klu ¨ver–Barrera staining for simultaneous visualization of cell
bodies and myelinated axon ﬁbers revealed massive disorganiza-
tion of the corpus callosum with loss of myelinated association
ﬁbers and prominent astrogliosis (Fig. 7).
Thus, the hippocampal formation and the corpus callosum
represent the areas of the brain that were speciﬁcally and dra-
matically affected by the altered longevity-assurance activity of
p53:p44 in APP695 ⁄ swe mice. Although the corpus callosum is
contributed by cortical neurons, we did not observe widespread
degeneration of the neocortex (see Fig. S4A) suggesting a very
selective form of neurodegeneration. The above phenotype was
evident under two different genetic backgrounds (see Experi-
mental Procedures), in both males and females, and could be
observed as early as 2.5 months of age before natural death of
the animals.
We previously showed that hyperactivation of IGF-1R signal-
ing results in increased levels of BACE1 and increased produc-
tion of Ab (Costantini et al., 2006). Accordingly, the analysis of
total brain homogenates revealed a 2-fold increase in Ab levels
in p44
+ ⁄ +;APP695 ⁄ swe mice when compared to APP695 ⁄ swe
ii i
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Fig. 6 Early loss of synaptic terminals in p44
+ ⁄ +;APP695 ⁄ swe double-transgenic mice. (A) Timm’s sulﬁde silver staining of coronal brain sections of 1.5-month-old
non-Tg (i, iii, v) and p44
+ ⁄ +;APP695 ⁄ swe mice (ii, iv, vi). Images (iii)t o( vi) show higher magniﬁcation of (i) and (ii). When compared to non-Tg, double-transgenic
animals displayed a severe loss of Timm’s staining. Speciﬁcally, the mossy ﬁbers (mf) showed a reduced staining whereas the ipsilateral and commissural
hippocampodentate pathways (black arrows), the commissural and ipsilateral association systems in the CA1-CA3 stratum oriens and stratum radiatum (black
arrow-heads), and the lateral perforant path (white arrows) could not be stained at all. Abbreviations: mf, mossy ﬁbers; ml, dentate molecular layer; sl, CA3
stratum lucidum; so, stratum oriens; sr, stratum radiatum. Scale bars: 500 lm( i and ii) and 100 lm( iii-vi). APP695 ⁄ swe and p44
+ ⁄ + animals are shown in Fig. S8. (B)
Representative microphotographs showing synaptophysin immunoreactivity (red) in brain sections of non-Tg and p44
+ ⁄ +;APP695 ⁄ swe mice. Nuclei were
counterstained with 4¢,6-diamidino-2-phenylindole (DAPI) (blue). The ‘synaptic boutons’ are well visible in non-Tg mice but signiﬁcantly reduced in double-
transgenic mice. Scale bar: 25 lm. Graphic in right panel shows relative optical density (OD) quantiﬁcation of synaptophysin immunoreactivity from CA1 stratum
radiatum (st. rad.), CA3 stratum lucidum (st. luc.), molecular layer of dentate gyrus (mol. layer DG) and polymorph layer of dentate gyrus (pol. layer DG). Values are
mean ± SEM. *P < 0.05, **P < 0.005.
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180single-transgenics (Fig. 8A). Importantly, p44
+ ⁄ );APP695 ⁄ swe lit-
termates did not display increased production of Ab (Fig. 8A). In
fact, it is already known that IGF-1R hyperactivation, as caused
by altered longevity-assurance activity of p53:p44, is only evi-
dent in homozygous animals. As a result, p44
+ ⁄ ) heterozygous
mice have normal lifespan (Maier et al., 2004). The increased
production of Ab in p44
+ ⁄ +;APP695 ⁄ swe double-transgenics was
paralleled by increased levels of Ab oligomers (Fig. 8B), although
classical amyloid plaques were never observed in the young dou-
ble-transgenics (Fig. 8C). Ab small aggregates have been pro-
posed as one of the possible causes of neuronal injury and
synaptic damage in a variety of AD-like models (Klein et al.,
2001; Cleary et al., 2005; Santacruz et al., 2005; Lesne et al.,
2006; Cheng et al., 2007). Importantly, we only detected
increased levels of the high-molecular and neurotoxic Ab species
(> 8-mer), which mostly correspond to nonameric (40-kDa)
and dodecameric (56-kDa; Ab*56) aggregates (Fig. 8B).
Although absent in 2.5-month-old p44
+ ⁄ +;APP695 ⁄ swe double-
transgenics and APP695 ⁄ swe single-transgenics, amyloid plaques
were evident in 18-month-old APP695 ⁄ swe mice (Fig. 8C), sug-
gesting that the early death of the double-transgenic animals
does not allow natural formation of plaques.
The neurodegeneration in p44
+ ⁄ +;APP695 ⁄ swe mice is
apoptosis-independent and appears to involve both
paraptosis- and autophagy-like events
To investigate the mechanisms of the neuronal death, we ini-
tially analyzed the mRNA levels of common p53 pro-apoptotic
targets, such as Puma, Noxa, and Bax. However, we did not
observe any difference between p44
+ ⁄ +;APP695 ⁄ swe double-
transgenics and their non-Tg littermates (data not shown). This
ﬁnding is not completely surprising because the pro-apoptotic
functions of p53 are linked to its tumor suppressor activity but
not to its longevity-assurance activity [reviewed in (Bauer & Helf-
and, 2006; Rodier et al., 2007; Ungewitter & Scrable, 2008)].
Consistently, we could not detect caspase activation, poly(ADP-
ribose) polymerase (PARP) cleavage, or DNA fragmentation as
assessed by TUNEL staining (data not shown). Therefore, in light
of these results we had to rule out apoptosis as the main mecha-
nism of neuronal death in our animals.
To further investigate the mechanisms of the cell death, we
analyzed different areas of the hippocampal formation with
transmission electron microscopy. We consistently observed two
different types of cells, which display characteristics of two dif-
ferent types of programmed cell death. The ﬁrst is represented
by neurons that preserved their overall shape, did not display
cellular blebbing, and maintained normal nuclei with smooth
margins and no evidence of chromatin-clumping. These neurons
appeared as lightly stained (see Fig. 9A; see also Fig. S9). Their
cytoplasm displayed different collections of tightly packed cyto-
plasmic vacuoles, which often occupied a signiﬁcant portion of
the cell body. In some cases the vacuoles appeared as swollen
and degenerating mitochondria; they were observed both inside
the neuronal cell bodies and in the surrounding neuropil. In a
few cases, the neurons were distorted by the presence of
numerous large vacuoles (see Fig. S9). These ‘vacuolar-degener-
ating neurons’ co-existed with a second type of cells represented
by darkly stained neurons (Fig. 9B; see also Fig. S9) displaying
cell shrinkage, condensed nuclei, chromatin clustering, and ruf-
ﬂing of the plasma membrane. The chromatin clustering was
different from the typical apoptosis-like condensation and
appeared more like loose speckles and irregular peripheral bun-
dles. The nuclear abnormalities included invagination and dis-
ruption of the nucleolemma (Fig. S9). In addition, these dark
degenerating neurons displayed accumulation of lysosomes and
dilated endoplasmic reticulum, Golgi apparatus, and mitochon-
dria (Fig. 9B). The features displayed by the lightly stained and
vacuolar-degenerating neurons are reminiscent of paraptosis,
whereas those displayed by the darkly stained neurons are remi-
niscent of autophagic cell death. Both paraptosis and autophagy
are caspase- and apoptosis-independent forms of cell death that
have been previously described in ex vivo and in vivo settings
[reviewed in (Broker et al., 2005; Leist & Jaattela, 2001)]. Impor-
tantly, the presence of dark degenerating neurons has already
been reported in both patients with AD (Nixon et al., 2005) and
AD-like mouse models (Yang et al., 2008).
Paraptosis, as well as autophagic cell death, cannot be recog-
nized with standardized in vitro biochemical assays. As a result,
it is currently deﬁned by its morphological features and by the
absence of caspase activation or apoptosis-related markers
[reviewed in (Broker et al., 2005; Leist & Jaattela, 2001)]. How-
ever, when initially described in a cellular model of IGF-1R hyper-
activation (Sperandio et al., 2000), paraptosis appeared to be
accompanied by activation of mitogen-activated protein kinases
i
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Fig. 7 Degeneration of the corpus callosum in p44
+ ⁄ +;APP695 ⁄ swe double-
transgenic mice. Luxol fast blue-Cresyl violet (Klu ¨ver–Barrera) staining of 2.5-
month-old non-Tg and p44
+ ⁄ +;APP695 ⁄ swe mice. Coronal brain sections at
comparable anteroposterior levels are shown. Immunostaining for GFAP
(green; iii, iv) of areas indicated in (i) and (ii) reveals that the myelin loss in
p44
+ ⁄ +;APP695 ⁄ swe mice is accompanied by prominent astrogliosis (green, iv).
Nuclei were counterstained with 4¢,6-diamidino-2-phenylindole (DAPI) (blue,
iii and iv). Scale bars: 500 lm( i and ii); 250 lm( iii and iv).
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181(MAPK) and Jun N-terminal kinases (JNK). As overexpression of
p44 can cause hyperactivation of IGF-1R signaling [(Costantini
et al., 2006; Maier et al., 2004); see also Fig. 2A], we investi-
gated whether p44
+ ⁄ +;APP695 ⁄ swe mice displayed increased
phosphorylation (activation) of MAPK and JNK. Analysis of hip-
pocampal tissue of the double-transgenics revealed a signiﬁcant
increase in the phosphorylation of both JNK (p54 and p46) and
MAPK (p44 and p42), when compared to non-Tg animals
(Fig. 9C,D). Interestingly, p44
+ ⁄ + single-transgenics also dis-
played increased phosphorylation of JNK and MAPK, although
only JNK reached statistical signiﬁcance (Fig. 9C,D). In addition
to IGF-1R, paraptosis can also be induced by TAJ⁄TROY, a mem-
ber of the tumor necrosis factor receptor superfamily (Wang
et al., 2004). However, we did not detect increased levels of
TAJ⁄TROY or PDCD5, a downstream target of TAJ⁄TROY, in our
animals (data not shown) excluding the involvement of this
upstream effector.
When taken together, the above results indicate that the neu-
rodegeneration observed in the brain of p44
+ ⁄ +;APP695 ⁄ swe dou-
ble-transgenic animals is caspase- and apoptosis-independent;
they also suggest that both paraptosis- and autophagy-like
pathways might be involved, likely through the interplay of dif-
ferent signaling machineries that require interaction of IGF-1R
with APP (or its proteolytic derivatives).
Igf1r haploinsufﬁciency improves the synaptic
deﬁcits of APP695 ⁄ swe transgenic mice
The results obtained with p44
+ ⁄ +;APP695 ⁄ swe double-transgenics
indicate that hyperactivation of IGF-1R signaling, as caused by
A
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Fig. 8 p44
+ ⁄ +;APP695 ⁄ swe transgenic mice have increased levels of Ab but no amyloid plaques. (A) Soluble Ab levels were measured by sandwich ELISA in brain
homogenates (neocortex) of 2.5-month-old mice. p44
+ ⁄ +;APP695 ⁄ swe mice display a 2-fold increase in the levels of both Abtotal and Ab42. No difference was
observed with the Ab42 ⁄ Abtotal ratio. Similar results were obtained in the hippocampus (data not shown). (B) Ab oligomers were immunoprecipitated from brain
homogenates (neocortex) with antibody 6E10 and analyzed by Western blot. The ‘Ab-bands’ shown here were identiﬁed with 6E10 antibody (against aa. 1-16 of
the Ab region of APP), but not with 22C11 (against the N-terminus of APP), indicating that they are neither degradation nor cleavage-end products of APP. In
addition, the above bands were not detected with AB5352, which recognizes C-terminal fragments of APP. The molecular masses correspond to previously
published and characterized Ab oligomers (Lesne et al., 2006). The 12-, 9-, 6-mer bands correspond to dodecameric (56-kDa), nonameric (40-kDa), and hexameric
(27-kDa) Ab aggregates. sAPP is also visible below the 110-kDa molecular marker. The graphic in the right panel shows relative optical density (OD) quantiﬁcation
of the indicated Ab immunoreactive bands (expressed as percentage of APP695 ⁄ swe mice). Animals were 2.5-month old when analyzed. (C) Immunostaining of Ab
deposits in the hippocampus and neocortex of 2.5-month-old p44
+ ⁄ +;APP695 ⁄ swe, age-matched APP695 ⁄ swe, and 18-month-old APP695 ⁄ swe mice. Classical
amyloid plaques were only observed in the old APP695 ⁄ swe animals. Scale bar (hippocampus): 500 lm. Scale bar (neocortex): 200 lm. All values are mean ± SEM.
*P < 0.05, **P < 0.005.
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Fig. 9 Both paraptosis- and autophagy-like events are responsible for the neuronal degeneration in p44
+ ⁄ +;APP695 ⁄ swe double transgenics. (A) Electron
micrographs showing neurons undergoing paraptosis-like degeneration (i and ii). These neurons appeared lightly stained and preserved their overall morphology
with normal nuclei and no evidence of chromatin condensation. Their cytoplasm displayed vacuoles and swollen mitochondria. iii and iv show higher magniﬁcation
of the indicated areas in i and ii, respectively. p44
+ ⁄ +;APP695 ⁄ swe double-transgenic mice also displayed dystrophic processes surrounding degenerating neurons
(*, asterisk). Dilated ER (iv) and mitochondria (iii and iv), together with several cytoplasmic inclusions (iii and iv), are evident. The swollen mitochondria showed
ruptured inner membranes (iii and iv). Scale bar: 2 lm for i and ii;1lm for iii and iv. Low-magniﬁcation images are shown in Fig. S9. Animals were 2.5-month old
when analyzed. (B) Electron micrographs showing neurons undergoing dark cell degeneration (i and ii). They were strongly stained with osmium and displayed
irregular morphology with highly electron dense cytoplasm containing dense vacuoles, swollen mitochondria and dilated ER-Golgi network. The mitochondria had
very few cristae and exhibited rupture of the inner membrane. The nucleus appeared highly condensed with crenated nucleolemma and chromatin clustered in
peripheral bundles. iii and iv show higher magniﬁcation of the indicated areas in i and ii, respectively. Scale bar: 2 lm for i and ii;1lmf o riii and iv. Low-
magniﬁcation images are shown in Fig. S9. Animals were 2.5-month old when analyzed. (C and D) Jun N-terminal kinases (JNK) (C) and mitogen-activated protein
kinases (MAPK) (D) phosphorylation in the hippocampus of non-Tg, p44
+ ⁄ +, APP695 ⁄ swe and p44
+ ⁄ +;APP695 ⁄ swe mice. A representative Western blot of two
different animals is shown in the upper panel whereas the percentage of change is shown in the lower panel (n = 4). The levels of JNK and MAPK phosphorylation
were normalized against the levels of total JNK or MAPK protein, respectively. Animals were 2.5-month old when analyzed. Results are expressed as percentage of
non-Tg and are the mean ± SEM. * P < 0.05.
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183deregulated longevity-assurance activity of p53:p44, can
cause⁄accelerate an AD-like neuropathology in the mouse. The
fact that haploinsufﬁciency of the Igf1r gene can correct the syn-
aptic deﬁcits of p44
+ ⁄ + single-transgenics prompted us to test
whether IGF-1R is a valid pharmacologic target for the preven-
tion⁄treatment of the synaptic deﬁcits that occur in patients
with AD. For this purpose, we generated APP695 ⁄ swe;Igf1r
+ ⁄ )
double-transgenic mice and compared the synaptic functions of
the single- and double-transgenics. Figure 10(A) shows that the
double-transgenics displayed a signiﬁcant decrease in the levels
of both the total protein and the phosphorylated form of IGF-
1R. LTP assessment of APP695 ⁄ swe mice revealed a marked defect
in the late phase of LTP (Fig. 10B), in the absence of signiﬁcant
deﬁcits in the presynaptic component of the synaptic transmis-
sion (data not shown). Igf1r haploinsufﬁciency in APP695 ⁄ swe;
Igf1r
+ ⁄ ) double-transgenics restored the LTP trace, thus proving
that downregulation of IGF-1R signaling has positive effects
even in the case of APP-driven pathology (Fig. 10B). While this
manuscript was under preparation, Freude et al. (Freude et al.,
2009) reported that selective disruption of neuronal Igf1r reverts
the AD-like pathology of Tg2576 mice, thus conﬁrming our
present results.
Discussion
The implication of IGF-1R signaling in the regulation of aging
and age-associated events has been consistently demonstrated
in many organisms, including yeast, C. elegans, D. melanogas-
ter, and mammals [reviewed in (Bauer & Helfand, 2006; Rodier
et al., 2007)]. Recent work has also revealed a possible mecha-
nistic link between IGF-1R and age-associated neurodegenera-
tive diseases [reviewed in (Cohen & Dillin, 2008; Puglielli,
2008)]. Importantly, genetic variations that cause reduced IGF-
1R signaling appear to be beneﬁcial for old age survival and for
the preservation of cognitive functions in humans (van Heemst
et al., 2005; Suh et al., 2008).
We previously published that hyperactivation of IGF-1R signal-
ing, induced by the overexpression of D40p53 (p44), accelerates
a naturally occurring and age-associated TrkA-to-p75
NTR switch
in the brain that activates the lipid second messenger ceramide
(Costantini et al., 2005, 2006). Ceramide, in turn, regulates the
steady-statelevelsofBACE1andtheproductionofAb(Costantini
et al., 2005, 2006). At the mechanistic level, ceramide controls a
transient form of lysine acetylation of nascent BACE1 that
impacts the cellular levels of the mature and enzymatically active
b secretase (Costantini et al., 2007; Jonas et al., 2008; Ko &
Puglielli, 2009). Here, we report that when in the presence of a
‘humanized’ version of mouse APP, the hyperactivationof IGF-1R
signaling, as caused by altered p53:p44 longevity-assurance
activity, results in massive and widespread degeneration of
memory-forming and -retrieving areas of the brain. Mechanisti-
cally, the neurodegeneration of p44
+ ⁄ +;APP695 ⁄ swe double-trans-
genics was linked to a caspase- and apoptosis- independent form
of cell death, speciﬁcally to a combination of paraptosis- and
A
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Fig. 10 Down-regulation of IGF-1R improves the
synaptic deﬁcits of APP695 ⁄ swe animals. (A)
Expression levels of IGF-1R and phospho-IGF-1R
(p-IGF-1R) in the hippocampal formation of
non-Tg, APP695 ⁄ swe, APP695 ⁄ swe;Igf1r
+ ⁄ ), and
Igf1r
+ ⁄ ) animals. A representative Western blot of
2 different animals is shown in the left panel,
whereas the percentage of change is shown in the
right panel (n = 4). Animals were 2.5-month old
when analyzed. (B) Enhanced hippocampal CA1
long-term potentiation (LTP) in APP695 ⁄ swe;Igf1r
+ ⁄ )
transgenic animals. Theta burst stimulation (TBS)-
induced LTP was enhanced in APP695 ⁄ swe;Igf1r
+ ⁄ )
[n = 10(3)] compared to APP695 ⁄ swe animals
[n = 13(3)]. Non-Tg mice [11(4)] are also shown.
Insets: example traces before and after LTP for each
transgenic group. Calibration 1 mV, 1 ms. No
difference was observed in the paired-pulse
facilitation (PPF) or i ⁄ o curves (data not shown).
Animals were 2.5-month old when analyzed. All
values are mean ± SEM. *P < 0.05; #P < 0.0005.
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184autophagy-like events. A caspase-driven form of neuronal death
that follows the classical apoptosis pathway has been clearly and
consistently documented in the developing brain. However, the
evidence for a similar pathway in the adult brain is often limited
[reviewed in (Leist & Jaattela, 2001)]. In fact, although some
degree of classical caspase-dependent apoptosis can occur in
the adult brain, mixed features of cell death are often observed.
As a result, it is generally thought that at least part of the cell
death in chronic neurodegenerative diseases is caused by alter-
native mechanisms [reviewed in (Leist & Jaattela, 2001)]. Auto-
phagy can inﬂuence both cell survival and cell death (Nixon,
2006; Lee, 2009). In fact, a fully functioning autophagic system
can help turn over organelles, cytoplasmic constituents, and
toxic protein aggregates. However, when dysfunctional, auto-
phagy can cause accumulation of autophagic vacuoles and trig-
ger other forms of cell death (Nixon, 2006; Lee, 2009). Although
the precise mechanisms of autophagy activation in neurodegen-
erative diseases are still being evaluated, it is now evident that,
when dysfunctional, it represents an important form of cell
death in both AD and non-AD forms of neurodegeneration
(Nixon, 2006; Lee, 2009). Paraptosis was initially described in ex
vivo settings as a result of hyperactivation of IGF-1R signaling
(Sperandio et al., 2000). Although it does not appear to have
clearly recognizable biochemical markers, paraptosis has been
linked toincreased phosphorylation ofthe MAPK⁄JNK system, at
least under conditions that involve IGF-1R activity (Sperandio
et al., 2004). Therefore, our results reinforce the idea that
the phenotype of p44
+ ⁄ +;APP695 ⁄ swe mice depends heavily on
the hyperactivation of IGF-1R signaling, which is caused by the
altered longevity-assurance activity of the p53:p44 system. It is
worth noting that the ability of IGF-1R to cause cell death has
also been documented before, both in ex vivo and in vivo set-
tings (Liu et al., 1993, 1998; Plymate et al., 1997; Hongo et al.,
1998). The fact that neither paraptosis nor autophagic cell death
was observed in age-matched p44
+ ⁄ + single-transgenics sug-
gests that activation of the MAPK⁄JNK system alone, as a result
of IGF-1R hyperactivation, is not enough to commit the neurons
to death, at least in vivo. This is not entirely surprising as neurons
differ from cultured cell lines and appear to possess alternative
systems that ‘buffer’ pro-death signals [reviewed in (Leist & Jaat-
tela, 2001)]. Therefore, it is likely that the ultimate commitment
to death is caused by the interplay of different signaling machin-
eries requiring, at least in our model, interaction of IGF-1R with
APP (or its proteolytic derivatives). Further characterization and
understanding of this novel form of cell death (paraptosis) and
its apparent close relationship with autophagy in our double-
transgenic mice might help us understand the events responsible
for age-associated neurodegenerative diseases and open new
perspectives for theirtreatment.
Both the hippocampal formation and the corpus callosum are
affected very early in AD (Hyman et al., 1984; Teipel et al.,
2003; Pogarell et al., 2005) and play important roles in memory
functions. In addition to AD, alterations of the corpus callosum
are found in schizophrenia, chronic epilepsy, and autism (Paul
et al., 2007). Similarly, alterations of the afferent path together
with abnormalities of the hippocampus are also observed in epi-
lepsy (Kinney et al., 2007; Auer et al., 2008). Although the
above disorders do not share all the other features that were
observed in the double-transgenics, we did notice a slight pro-
pensity of the p44
+ ⁄ +;APP695 ⁄ swe animals to brief, spontaneous,
and noninducible seizures, which did not appear to affect the
normal life of the animals. Interestingly, hippocampal abnormal-
ities have been identiﬁed in a subset of sudden unexplained
death that occurs in otherwise normal children (Kinney et al.,
2007). The death appears to be caused by unwitnessed seizures
arising during sleep in the anomalous hippocampus and causing
cardiopulmonary arrest. In the absence of an evident cause of
death at autopsy and ancillary testing, the above represents a
viable explanation as the immediate cause of death of the dou-
ble-transgenics. Importantly, it is already known that overex-
pression of p44
+ ⁄ + in the mouse does not cause hypoglycemia
or other metabolic abnormalities that could result in sudden
death (Maier et al., 2004). Finally, isolated seizures have been
observed in other AD-like animal models (Westmark et al.,
2008) and are common in patients with advanced AD (Risse
et al., 1990; Menendez, 2005).
A previous report in aged rats suggested that plasma IGF-1
might enhance Ab clearance from the brain (Carro et al., 2002).
However, subsequent studies in several animal models, which
included APP-expressing mice, failed to detect changes in Ab
clearance, amyloid load, or in the phosphorylation status of tau,
ruling out any disease-modifying beneﬁts of an IGF-1 restorative
therapy (Lanz et al., 2008). Additionally, a recent study in
patients with AD found no cognitive beneﬁts when IGF-1 secre-
tion in the plasma was induced with the growth hormone (GH)
secretagogue MK-677 (Sevigny et al., 2008). These results are
not surprising. In fact, it is already known that brain IGF-1 is syn-
thesized locally, is not under the control of GH, and is not
affected by plasma⁄circulating IGF-1 [(Costantini et al., 2006;
Lupu et al., 2001; Sun et al., 2005), also reviewed in (Puglielli,
2008)]. Additionally, mutations that decrease the levels of IGF-
1R or block IGF-1R signaling extend lifespan and improve age-
associated manifestations, whereas hyperactivation of IGF-1R
signaling produces the opposite effects [reviewed in (Bauer &
Helfand, 2006; Kenyon, 2005; Puglielli, 2008; Rodier et al.,
2007)]. In the mouse, haploinsufﬁciency for Igf-1r or deletion of
insulin⁄IGF-1 receptor substrate 2 (Irs2), an essential component
of IGF-1R signaling, leads to increased lifespan and improved
cognitive⁄behavioral performance (Holzenberger et al., 2003;
Taguchi et al., 2007). Recent work from Freude et al. (Freude
et al., 2009) showed that IRS2 deﬁciency in the Tg2576 AD
mouse model reduced both the b cleavage of APP and the levels
of Ab in the brain and was able to reverse the premature mortal-
ity of the Tg2576 single-transgenics. Identical results were
obtained when Igf1r was selectively disrupted in the neurons of
Tg2576 animals (Freude et al., 2009). It is also worth noting that
studies in C. elegans indicate that IGF-1R signaling not only reg-
ulates longevity but also the cytotoxicity induced by protein
aggregates (Cohen et al., 2006; Cohen & Dillin, 2008). These
results are consistent with our present ﬁndings and suggest that
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185pharmacological targeting of IGF-1R should be explored for the
treatment⁄prevention of both the cognitive decline that accom-
panies aging and the neuropathology that characterizes late-
onset AD.
Experimental procedures
Transgenic mice
Animal experiments were carried out in accordance with the
NIH Guide for the Care and Use of Laboratory Animals and were
approved by the Institutional Animal Care and Use Committee
of the University of Wisconsin-Madison and the Madison Veter-
ans Administration Hospital. The animals described here were all
littermates and under the same genetic background (ICR and
mixed ICR · C57BL⁄6J). Details of breeding strategies and
genotyping are described in Supporting Information. The gener-
ation of p44
+ ⁄ + single-transgenics has been described before
(Maier et al., 2004). Transgenic mice heterozygous for a tar-
geted disruption of Ifg1r gene (Igf1r
+ ⁄ )) were kindly provided by
Dr. A. Efstratiadis (Columbia University, New York) (Liu et al.,
1993). APP695 ⁄ swe and Tau
) ⁄ ) transgenic mice were from The
Jackson Laboratory (Bar Harbor, Maine, USA). The normal hus-
bandry of the mice has already been described (Maier et al.,
2004; Costantini et al., 2005, 2006).
Behavioral and cognitive testing
Animals were housed in less than four per cage, and all mice in a
single cage were trained and tested at the same time. Mice were
allowed to acclimate to the room for 30 min prior to training or
testing. Only standard and widely used behavioral⁄cognitive
tests (open ﬁeld, fear conditioning to cue and context, and
Barnes maze) were employed in this study. Details are described
in Supporting Information.
Electrophysiology
As described in the Supporting Information, 400 lM transverse
hippocampal slices from 2.5-month-old mice were prepared.
LTP was induced with theta burst stimulation applied to the
Schaffer collaterals, at the border of CA3 and CA1, and ﬁeld
EPSPs were measured in stratum radiatum. Theta burst stimula-
tion consisted of ten bursts⁄train, and three trains⁄stimulus with
a 20-s intertrain interval. Each burst contained four stimulations
at 100 Hz with an interburst interval of 200 ms. A detailed
description of the procedure is found in the Supporting Informa-
tion.
Histology and immunostaining
Animals were euthanized according to the NIH Guide for the
Care and Use of Laboratory Animals. The brains were dissected,
ﬁxed overnight in 10% neutral buffered formalin, and parafﬁn-
embedded using standard techniques. Coronal tissue sections
(5 lm) were prepared using a microtome. Following standard
deparafﬁnization and rehydration, the tissue sections were pro-
cessed for Hematoxylin and Eosin (H&E) staining or immunoﬂuo-
rescence. Antigen retrieval for immunoﬂuorescent staining was
performed in 100 mM of citrate buffer (pH 6) heated in an auto-
clave. After washing with PBS, tissue sections were permeabi-
lized with 0.1% Triton X-100 in PBS and blocked for 2 h with
10% goat serum, 2% bovine serum albumin, and 0.1% Triton
X-100 in PBS. Sections were then incubated with primary anti-
bodies (diluted in blocking solution) overnight at 4  C. After
washing with PBS, they received ﬂuorophore- or biotin-conju-
gated (anti-rabbit or anti-mouse) secondary antibodies for 1 h
at room temperature. Nuclei were counterstained with 4¢,6-di-
amidino-2-phenylindole (DAPI; Molecular Probes-Invitrogen,
Carlsbad, CA, USA). Slides were mounted using Gel⁄Mount
aqueous mounting medium (Electron Microscopy Sciences, Hat-
ﬁeld, PA, USA).
The following primary antibodies were used: rabbit anti-GFAP
(polyclonal; 1:500; Dako, Carpinteria, CA, USA), mouse anti-
NeuN (clone A60; 1:200; Chemicon-Millipore; Billerica, MA,
USA), mouse anti-PHF-Tau (clone AT8; 10 lg⁄mL; Innogenetics-
AutogenBioclear, Calne, UK), rabbit anti-phospho-S356-Tau
(polyclonal; 1:100; Abcam; Cambridge, MA, USA), and rabbit
anti-synaptophysin (monoclonal [YE269]; 1:250; Abcam).
Secondary antibodies were Alexa 488- and Alexa 594-conju-
gated goat anti-rabbit (5 lg⁄mL; Molecular Probes-Invitrogen)
for GFAP and synaptophysin, respectively. For NeuN and PHF-
Tau-AT8 immunoﬂuorescence, the secondary antibodies were
biotin-labeled goatanti-mouse (5 lg⁄mL;Molecular Probes-Invi-
trogen)followedbyAlexa488-orAlexa594-conjugated strepta-
vidin (5 lg⁄mL; Molecular Probes-Invitrogen). Controls were
performed by omitting the primary antibody. Kluver–Barrera
method (Luxol Fast Blue-Cresyl Echt Violet; Poly Scientiﬁc, Bay
Shore, NY, USA) for myelin and nerve cells was performed fol-
lowing the manufacturer’s instructions. Beta-amyloid staining
was performed using Beta-Amyloid mouse monoclonal antibody
(clone6F⁄3D;1⁄50; Novocastra,Newcastle uponTyne,UK)after
pretreatment oftissue sections with formic acidfor 30 min.
Processed slides were imaged on a Zeiss Axiovert 200 inverted
ﬂuorescent microscope. Quantiﬁcation of relative optical densi-
ties (ROD) of synaptophysin staining was performed in synapto-
physin-immunolabeled coronal sections imaged at X20 using
Scion-Image software. Measurements were performed in at
least three brain sections for each animal. Mean ROD values
were reported as percentage of non-Tg mice. Statistical analysis
was performed using one-way ANOVA followed by Tukey–Kramer
multiple comparisons test. Differences were declared statistically
signiﬁcant if P < 0.05.
Timm’s sulﬁde silver staining was performed in 1.5-month-old
male mice following the procedure described by Sloviter (Slovit-
er, 1982). Brieﬂy, mice were perfused transcardially with a
0.37% sodium sulﬁde solution (phosphate-buffered) for 5 min,
followed by 10% neutral-buffered formalin for additional
5 min. Brains were then removed, incubated overnight in
formalin, and processed for parafﬁn embedding. Coronal tissue
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tion prepared immediately before use (Sloviter, 1982). Sections
from all genotypes were processed together in the same rack.
Development was stopped by incubation in tap water, and slides
were counterstained with cresyl violet. Slides were then dehy-
drated and mounted with VectaMount Permanent Mounting
Medium (Vector labs, Burlingame, CA, USA).
Electron microscopy
Transmission electron microscopy was performed at the Electron
Microscopy Facility of the University of Wisconsin-Madison,
using 2.5% glutaraldehyde in phosphate buffer (pH 7.2) as a
ﬁxer (Oberley et al., 2008). Tissues were rinsed in Sorenson’s
phosphate washing buffer, postﬁxed in Caulﬁeld’s osmium
tetroxide plus sucrose, and rinsed again in washing buffer. All
supplies and reagents were from Electron Microscopy Sciences
(Hatﬁeld, PA, USA). Tissues were dehydrated in a graded series
of ethanol and propylene oxide and embedded in BEEM
  cap-
sules using EMbed-812 resin. Polymerization was thermally
induced overnight in a 60  C oven. Thin sections (70–80 nm)
were cut and mounted on copper grids, stained with ﬁltered
7.7% uranyl acetate and counterstained with Reynolds lead cit-
rate. Tissue sections were observed using a transmission electron
microscope (Hitachi H-600) operated at 75 kV.
Western blot analysis
Protein extracts from the hippocampus of 2.5-month-old trans-
genic and nontransgenic littermates were prepared in GTIP buf-
fer (100 mM Tris pH 7.6, 20 mM EDTA, 1.5 M NaCl)
supplemented with 1% Triton X-100 (Roche, Indianapolis, IN,
USA), 0.25% NP40 (Roche), complete protein inhibitors cocktail
(Roche), and phosphatases inhibitors (cocktail set I and set II;
Calbiochem-EMD, San Diego, CA, USA). Protein concentration
was measured by the bicinchoninic acid method (Pierce-Thermo
Scientiﬁc, Rockford, IL, USA). Protein samples (20 or 40 lg) pre-
pared in reducing NuPAGE
  LDS Sample Buffer (Invitrogen)
were subjected to electrophoresis using precast NuPAGE
 
Novex 4–12% Bis-Tris gels (Invitrogen) and transferred to nitro-
cellulose membranes (Invitrogen). Membranes were blocked for
1 h in Tris-buffered saline–0.1% Tween
 20 (TBST) containing
5% nonfat dry milk, followed by an overnight incubation with
primary antibody diluted in 5% BSA in TBST. After washing with
TBST, the membrane was incubated with peroxidase-conju-
gated secondary antibody (Amersham Biosciences-GE Health-
care, Piscataway, NJ, USA) for 1 h and developed using the
LumiGLO chemiluminescent detection system (KPL; Gaithers-
burg, MD, USA). The following primary antibodies were used:
anti-IGF-1 Receptor b (111A9) (1:1000; Cell Signaling, Danvers,
MA, USA), anti-phospho-IGF-1 Receptor (Tyr1135⁄1136)⁄Insu-
lin Receptor (Tyr1150⁄1151) (19H7) (1:1000; Cell Signaling),
anti-tau (TAU-5) (1:1000; Invitrogen-BioSource ), anti-b-actin
(1:1000; Cell Siganling), anti-SAPK⁄JNK (1:1000; Cell Signaling),
anti-phospho-SAPK⁄JNK (Thr183⁄Tyr185) (1:1000; Cell Signal-
ing), anti-p44⁄42 MAPK (137F5) (1:1000; Cell Signaling), anti-
phospho-p44⁄42 MAPK (Erk1⁄2) (Thr202⁄Tyr204) (D13.14.4E)
(1:2000; Cell Signaling). Densitometric analysis was performed
using the NIH Image program.
Ab determination
Ab levels were determined by standard sandwich ELISA using
Beta-Amyloid 1–40 and 1–42 ELISA kits from Signet Laborato-
ries (Covance, Princeton, NJ, USA) according to the protocol
provided by the manufacturer. Samples were assayed by tripli-
cate, and the levels of Ab40, Ab42, and Abtotal were deter-
mined based upon standard curves run on every ELISA plate and
then expressed as ng Ab⁄g total protein.
Immunoprecipitation and Western blot for Ab
oligomers
Forebrain protein extracts from 2.5-month-old APP695 ⁄ swe and
double-transgenic p44
+ ⁄ +;APP695 ⁄ swe mice were prepared as
described earlier. Immunoprecipitation was performed using
6E10 monoclonal antibody (against Ab1–16;1 ⁄100, Signet-
Covance, Berkeley, CA, USA) and ExactaCruz
TM E immunopre-
cipitation kit (Santa Cruz Biotechnolgy; Santa Cruz, CA, USA),
to eliminate IP antibody detection in the subsequent Western
blot analysis. Brieﬂy, the protein extracts (500 lg diluted to
1 lg⁄lL) were precleared with Preclearing Matrix E for 30 min
at 4  C, transferred to the 6E10 antibody-IP matrix complex,
and incubated overnight at 4  C with slow rotation. After wash-
ing, pelleted matrix was resuspended in 30 lLo f2 · reducing
NuPAGE
  LDS Sample Buffer (Invitrogen) and boiled for 5 min.
Samples were subjected to electrophoresis using precast
NuPAGE
  Novex 4–12% Bis-Tris gels (Invitrogen) and trans-
ferred to nitrocellulose membranes (Invitrogen). Membranes
were boiled for 5 min in PBS, blocked in Tris-buffered saline–
0.1% Tween
 20 (TBST) for 1 h and incubated for 2 h with 6E10
monoclonal antibody (1⁄200) diluted in ExactaCruz E dilution
buffer. After washing with TBST, membranes were incubated
for 1 h with ExactaCruz E Western Blot Reagent (1⁄1000) and
then washed and developed as described earlier. After stripping,
membranes were reprobed using monoclonal 22C11
(Chemicon-Millipore) or polyclonal APP C-terminus antibodies
(Chemicon-Millipore).
Statistical analysis
Data analysis was performed using GraphPad InStat 3.06 statisti-
cal software (GraphPad Software, San Diego, CA, USA). Data is
expressed as mean ± SEM. Comparison of the means was per-
formed using t-tests or one-way ANOVA followed by Tukey–Kra-
mer multiple comparisons test, unless otherwise noted. For
lifespan assessment, data were analyzed with the Kaplan–Meier
lifespan test and log-rank test using GraphPad Prism version 4.0
(GraphPad Software). Differences were declared statistically sig-
niﬁcant if P £ 0.05.
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Fig. S1 Open-ﬁeld test of p44
+ ⁄ + transgenic mice.
Fig. S2 Short-term facilitation and basal synaptic transmission in
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189Fig. S3 Histology of peripheral organs from non-Tg and
p44
+ ⁄ +;APP695 ⁄ swe double-transgenic mice.
Fig. S4 Histology of neocortex, cerebellum, and spinal cord of
non-Tg and p44
+ ⁄ +;APP695 ⁄ swe double-transgenic mice.
Fig. S5 Histology of the hippocampus and dentate gyrus of
APP695 ⁄ swe, p44
+ ⁄ ), p44
+ ⁄ );APP695 ⁄ swe, and p44
+ ⁄ + animals.
Fig. S6 Widespread astrogliosis in the hippocampus and dentate
gyrus of p44
+ ⁄ +;APP695 ⁄ swe transgenic mice.
Fig. S7 Abnormal phosphorylation of the microtubule-associ-
ated protein tau in the hippocampus and dentate gyrus of
p44
+ ⁄ +;APP695 ⁄ swe transgenic mice.
Fig. S8 Loss of Timm’s staining in p44
+ ⁄ +;APP695 ⁄ swe double-
transgenic mice.
Fig. S9 Evidence of paraptosis- and autophagy-like cell death in
the hippocampus of p44
+ ⁄ +;APP695 ⁄ swe double-transgenic mice.
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